UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 125

Sortiert nach

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study

European journal of cancer (1990), 2014-01, Vol.50 (2), p.388-396

2014

Volltextzugriff (PDF)

Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues

Cancer research (Chicago, Ill.), 1992-06, Vol.52 (12), p.3396-3401

1992

Volltextzugriff (PDF)

Subacute Measles Encephalitis in the Young Immunocompromised Host: Report of Two Cases Diagnosed by Polymerase Chain Reaction and Treated with Ribavirin and Review of the Literature

Clinical infectious diseases, 1993-05, Vol.16 (5), p.654-660

1993

Volltextzugriff (PDF)

Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group Study

Journal of clinical oncology, 1993-12, Vol.11 (12), p.2324-2329

1993

Volltextzugriff (PDF)

The folate receptor as a potential therapeutic anticancer target

Investigational new drugs, 1998-01, Vol.16 (3), p.205-219

1998

Volltextzugriff (PDF)

The folate receptor in central nervous system malignancies of childhood

Journal of neuro-oncology, 1994-01, Vol.21 (2), p.107-112

1994

Volltextzugriff (PDF)

Phase I trial of 9-aminocamptothecin in children with refractory solid tumors: a Pediatric Oncology Group study

Journal of clinical oncology, 1998-07, Vol.16 (7), p.2494-2499

1998

Volltextzugriff (PDF)

Hepatocellular carcinoma in children associated with Gardner syndrome or familial adenomatous polyposis

Journal of pediatric hematology/oncology, 1998-05, Vol.20 (3), p.274-278

1998

Volltextzugriff (PDF)

Back to the basics: the importance of concentration x time in oncology

Journal of clinical oncology, 1993-05, Vol.11 (5), p.820-821

1993

Volltextzugriff (PDF)

Toxicity, pharmacokinetics, and in vitro hemodialysis clearance of ifosfamide and metabolites in an anephric pediatric patient with Wilms' tumor

Cancer chemotherapy and pharmacology, 1998, Vol.41 (2), p.140-146

1998

Volltextzugriff (PDF)

Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis

Cancer research (Chicago, Ill.), 1992-12, Vol.52 (23), p.6708

1992

Volltextzugriff (PDF)

Accumulation of 5‐methyltetrahydrofolic acid and folylpolyglutamate synthetase expression by mitogen stimulated human lymphocytes

British journal of haematology, 1993-08, Vol.84 (4), p.595-601

1993

Volltextzugriff (PDF)

Pulmonary Toxicity of Deferoxamine in Children With Advanced Cancer

JNCI : Journal of the National Cancer Institute, 1991-12, Vol.83 (24), p.1834-1836

1991

Volltextzugriff (PDF)

Liquid chromatography–mass spectrometry assay of a thiadiazole derivative in mice: application to pharmacokinetic studies

Journal of chromatography. B, Biomedical sciences and applications, 2001-12, Vol.765 (1), p.55-62

2001

Volltextzugriff (PDF)

High-Dose Methotrexate: Is it Warranted?

Pediatric hematology and oncology, 1994, Vol.11 (2), p.135-137

1994

Volltextzugriff (PDF)

Pharmacokinetic Evaluation of a New Oral Cyclosporine Formulation

Pharmacotherapy, 1994-01, Vol.14 (1), p.105-110

1994

Volltextzugriff (PDF)

Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units

Anti-cancer drugs, 1999-10, Vol.10 (9), p.837-844

1999

Volltextzugriff (PDF)

Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units

Anti-cancer drugs, 1999-03, Vol.10 (3), p.309-315

1999

Volltextzugriff (PDF)

Phase I study of lorvotuzumab mertansine (LM, IMGN901) in combination with lenalidomide (Len) and dexamethasone (Dex) in patients with CD56-positive relapsed or relapsed/refractory multiple myeloma (MM)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8013-8013

2011

Volltextzugriff (PDF)

Fosfomycin-Friend or Foe?

Pediatric hematology and oncology, 1991-01, Vol.8 (3), p.vii-viii

1991

Volltextzugriff (PDF)

Comparison of DX-8951f and topotecan effects on tumor colony formation from freshly explanted adult and pediatric human tumor cells

Anti-cancer drugs, 1999-08, Vol.10 (7), p.655-662

1999

Volltextzugriff (PDF)

Efficacy results from a phase I study of lorvotuzumab mertansine (IMGN901) in patients with CD56-positive solid tumors

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e13582-e13582

2011

Volltextzugriff (PDF)

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An EORTC Soft Tissue and Bone Sarcoma Group randomized phase II study

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10037-10037

2010

Volltextzugriff (PDF)

Significant activity of a novel cytotoxic agent, LY295501, against a wide range of tumors in the human tumor cloning system

Anti-cancer drugs, 1999-03, Vol.10 (3), p.303-307

1999

Volltextzugriff (PDF)

Direct Raman imaging techniques for study of the subcellular distribution of a drug

Applied optics (2004), 2002-10, Vol.41 (28), p.6006

2002

Volltextzugriff (PDF)

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(114)

Publikationsform

Artikel
(123)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study

Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues

Subacute Measles Encephalitis in the Young Immunocompromised Host: Report of Two Cases Diagnosed by Polymerase Chain Reaction and Treated with Ribavirin and Review of the Literature

Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group Study

The folate receptor as a potential therapeutic anticancer target

The folate receptor in central nervous system malignancies of childhood

Phase I trial of 9-aminocamptothecin in children with refractory solid tumors: a Pediatric Oncology Group study

Hepatocellular carcinoma in children associated with Gardner syndrome or familial adenomatous polyposis

Back to the basics: the importance of concentration x time in oncology

Toxicity, pharmacokinetics, and in vitro hemodialysis clearance of ifosfamide and metabolites in an anephric pediatric patient with Wilms' tumor

Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis

Accumulation of 5‐methyltetrahydrofolic acid and folylpolyglutamate synthetase expression by mitogen stimulated human lymphocytes

Pulmonary Toxicity of Deferoxamine in Children With Advanced Cancer

Liquid chromatography–mass spectrometry assay of a thiadiazole derivative in mice: application to pharmacokinetic studies

High-Dose Methotrexate: Is it Warranted?

Pharmacokinetic Evaluation of a New Oral Cyclosporine Formulation

Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units

Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units

Phase I study of lorvotuzumab mertansine (LM, IMGN901) in combination with lenalidomide (Len) and dexamethasone (Dex) in patients with CD56-positive relapsed or relapsed/refractory multiple myeloma (MM)

Fosfomycin-Friend or Foe?

Comparison of DX-8951f and topotecan effects on tumor colony formation from freshly explanted adult and pediatric human tumor cells

Efficacy results from a phase I study of lorvotuzumab mertansine (IMGN901) in patients with CD56-positive solid tumors

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An EORTC Soft Tissue and Bone Sarcoma Group randomized phase II study

Significant activity of a novel cytotoxic agent, LY295501, against a wide range of tumors in the human tumor cloning system

Direct Raman imaging techniques for study of the subcellular distribution of a drug

Suchergebnisse filtern